Literature DB >> 8049469

A dual requirement for neurogenic genes in Drosophila myogenesis.

M Bate1, E Rushton, M Frasch.   

Abstract

In wild-type embryos of Drosophila melanogaster, the formation of differentiated larval muscles is preceded by the segregation of small numbers of progenitor or founder cells in the embryonic mesoderm. The founder cells, characterised by the expression of genes encoding putative transcription factors such as S59 or vestigial, fuse with neighbouring myoblasts to form syncytial precursors of individual muscles. Founder cell segregation is deranged in embryos mutant for any of the neurogenic genes: enlarged clusters of cells expressing S59 or vestigial are detected at the sites where small numbers of founder cells segregate in the wild type. In addition, muscle differentiation is deranged in such embryos in a way that appears to be closely linked to the extent of epidermal disruption caused by the neurogenic phenotype: myoblast fusion is limited to regions of the mesoderm beneath the residual epidermis left by the hyperplasia of the nervous system, and late expression of S59 and vestigial is lost from mesoderm not lying within the margins of the residual epidermis. Thus neurogenic gene functions appear to be required both for the normal segregation of founder cells and for muscle differentiation. It is not clear whether either of these requirements reflects an essential function for any or all of the neurogenic genes within the mesoderm itself.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8049469

Source DB:  PubMed          Journal:  Dev Suppl


  16 in total

1.  Notch and wingless regulate expression of cuticle patterning genes.

Authors:  C S Wesley
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Embryonic even skipped-dependent muscle and heart cell fates are required for normal adult activity, heart function, and lifespan.

Authors:  Miki Fujioka; Robert J Wessells; Zhe Han; Jiandong Liu; Kerry Fitzgerald; Galina L Yusibova; Monica Zamora; Pilar Ruiz-Lozano; Rolf Bodmer; James B Jaynes
Journal:  Circ Res       Date:  2005-10-20       Impact factor: 17.367

3.  Org-1, the Drosophila ortholog of Tbx1, is a direct activator of known identity genes during muscle specification.

Authors:  Christoph Schaub; Hideyuki Nagaso; Hong Jin; Manfred Frasch
Journal:  Development       Date:  2012-03       Impact factor: 6.868

Review 4.  The complex tale of the achaete-scute complex: a paradigmatic case in the analysis of gene organization and function during development.

Authors:  Antonio García-Bellido; Jose F de Celis
Journal:  Genetics       Date:  2009-07       Impact factor: 4.562

5.  Combinatorial signaling codes for the progressive determination of cell fates in the Drosophila embryonic mesoderm.

Authors:  A Carmena; S Gisselbrecht; J Harrison; F Jiménez; A M Michelson
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

6.  Complex proteolytic processing acts on Delta, a transmembrane ligand for Notch, during Drosophila development.

Authors:  K M Klueg; T R Parody; M A Muskavitch
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

7.  Vestigial gene expression in Drosophila melanogaster is modulated by the dTMP pool.

Authors:  A Zider; D Flagiello; I Frouin; J Silber
Journal:  Mol Gen Genet       Date:  1996-04-24

8.  Drosophila SNS, a member of the immunoglobulin superfamily that is essential for myoblast fusion.

Authors:  B A Bour; M Chakravarti; J M West; S M Abmayr
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

9.  Inscuteable and numb mediate asymmetric muscle progenitor cell divisions during Drosophila myogenesis.

Authors:  A Carmena; B Murugasu-Oei; D Menon; F Jiménez; W Chia
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

10.  Vestigial-like-2b (VITO-1b) and Tead-3a (Tef-5a) expression in zebrafish skeletal muscle, brain and notochord.

Authors:  Christopher J Mann; Daniel P S Osborn; Simon M Hughes
Journal:  Gene Expr Patterns       Date:  2007-08-15       Impact factor: 1.224

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.